Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

Hirose, Hiroshi, Kawai, Toshihide, Yamamoto, Yukihiro, Taniyama, Matsuo, Tomita, Motowo, Matsubara, Koichi, Okazaki, Yasunori, Ishii, Tatsuya +3 more·2002·Metabolism

DOI 10.1053/meta.2002.30506

Cited by (235)

Items 101–200 of 235

Effects of Pioglitazone on Visceral Fat Metabolic Activity in Impaired Glucose Tolerance or Type 2 Diabetes Mellitus
Norihiro Kodama, Nobuhiro Tahara, Atsuko Tahara, Akihiro Honda, Yoshikazu Nitta, Minori Mizoguchi, Hayato Kaida, Masatoshi Ishibashi, Toshi Abe, Hisao Ikeda et al. · 2013 · The Journal of Clinical Endocrinology & Metabolism
13-cis-Retinoic acid therapy induces insulin resistance, regulates inflammatory parameters, and paradoxically increases serum adiponectin concentration
M. K. Heliövaara, Anita Remitz, Sakari Reitamo, Anna‐Maija Teppo, Sirkka-Liisa Karonen, Pertti Ebeling · 2007 · Metabolism
Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin
Takahiro Araki, Masanori Emoto, Megumi Teramura, Hisayo Yokoyama, Katsuhito Mori, Sawako Hatsuda, Takaaki Maeno, Kayo Shinohara, Hidenori Koyama, Tetsuo Shoji et al. · 2006 · Metabolism
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub‐study of the DREAM trial
Zubin Punthakee, N. Alméras, Jean‐Pierre Després, Gilles R. Dagenais, Sonia Savitri Anand, Dereck L. Hunt, Arya Mitra Sharma, Hyun Suk Jung, Salim Yusuf, Hertzel C. Gerstein · 2014 · Diabetic Medicine
Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?
Emily K. Calton, Veronica S Miller, Mário J. Soares · 2013 · European Journal of Clinical Nutrition
Cardiovascular Risk Factors Associated with Insulin Resistance: Effects of Oral Antidiabetic Agents
Granberry, Mark C, Fonseca, Vivian A · 2005 · American Journal of Cardiovascular Drugs
Effect of PPARα activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes
Kentaro Murakami, Hideaki Bujo, Hiroyuki Unoki‐Kubota, Yasushi Saitō · 2007 · European Journal of Pharmacology
Peroxisome Proliferator-Activated Receptor γ (PPAR-γ) Agonist Increases Plasma Adiponectin Levels in Type 2 Diabetic Patients with Proteinuria
Mahmut İlker Yılmaz, Alper Sönmez, Kayser Çağlar, Deniz Engin Gök, Tayfun Eyileten, Müjdat Yenicesu, Cengizhan Açıkel, Necati Bingöl, Selim Kılıç, Yusuf Oğuz et al. · 2004 · Endocrine
Implications of Rosiglitazone and Pioglitazone on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
Brian K. Irons, Ronald Shane Greene, Timothy A. Mazzolini, Krystal L. Edwards, Rebecca B. Sleeper · 2006 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a β3-adrenoceptor agonist
Fumiki Oana, Hiroo Takeda, Akane Matsuzawa, Satoshi Akahane, Masayuki Isaji, Masuo Akahane · 2005 · European Journal of Pharmacology
Impact of pioglitazone on bone mineral density and bone marrow fat content
Laurentiu M. Pop, Ildiko Lingvay, Qing Yuan, X. Li, BEVERLEY A. ADAMS-HUET, Naim M. Maalouf · 2017 · Osteoporosis International
The 1st World Congress on the Insulin Resistance Syndrome
Zachary T. Bloomgarden · 2004 · Diabetes Care
Insulin and Endothelin in the Acute Regulation of Adiponectin in Vivo in Humans
Lori A. Brame, Robert V. Considine, Mikako Degawa‐Yamauchi, Alain Baron, Kieren J. Mather · 2005 · Obesity Research
Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction
Yoshimasa Aso, Ruriko Suganuma, Sadao Wakabayashi, Kenji Hara, Tomoki Nakano, Mariko Suetsugu, Sachiko Matsumoto, Takafumi Nakamachi, Kohzo Takebayashi, Kimio Morita et al. · 2009 · Translational research
SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model
Atsuo Tahara, Toshiyuki Takasu · 2019 · Physiological Reports
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome
Fabrizio Montecucco, François Mach · 2009 · Diabetes Obesity and Metabolism
Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS)
Georgios Valsamakis, Kostas Lois, Sudhesh Kumar, George P. Mastorakos · 2013 · HORMONES
Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes
Yoshimasa Aso, Kenji Hara, Noriyuki Ozeki, Chikako Yatsuka, Tomoki Nakano, Sachiko Matsumoto, Mariko Suetsugu, Takafumi Nakamachi, Kohzo Takebayashi, Kohsuke Haruki et al. · 2009 · Diabetes Research and Clinical Practice
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands and Their Therapeutic Utility
Brad R. Henke · 2004 · Progress in medicinal chemistry
Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content
Elizabeth Louise Thomas, Elizabeth Louise Potter, Isabella Tosi, Julie A. Fitzpatrick, Gavin Hamilton, Vian Amber, Robert I. Hughes, Christopher North, Paul Holvoet, Mary Seed et al. · 2007 · Atherosclerosis
Peroxisome proliferator-activated receptor-??2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2
Ioanna Gouni‐Berthold, Eleni Giannakidou, Dirk Müller‐Wieland, Michael Faust, Jörg Kotzka, Heiner K. Berthold, Wilhelm Krone · 2005 · Journal of Hypertension
Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats
Ali Amirinejad, Ali Saneei Totmaj, Farzaneh Mardali, Azita Hekmatdoost, Hadi Emamat, Majid Safa, Farzad Shidfar · 2021 · BMC Complementary Medicine and Therapies
Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots
Jun Goo Kang, Cheol‐Young Park, Sung‐Hee Ihm, Hyung Joon Yoo, Heesoon Park, Eun‐Jung Rhee, Jong Chul Won, Won‐Young Lee, Ki Won Oh, Sung Woo Park et al. · 2009 · Metabolism
Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes
Tae Sasakabe, Hajime Haimoto, Umegaki, Wakai · 2011 · Diabetes Metabolic Syndrome and Obesity
Comparison of the effects of pioglitazone and voglibose on circulating total and high‐molecular‐weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes
Yoshimasa Aso, Ruriko Yamamoto, Mariko Suetsugu, Sachiko Matsumoto, Sachiko Wakabayashi, Rika Matsutomo, Kohzo Takebayashi, Toshihiko Inukai · 2007 · Diabetic Medicine
Lessons in obesity from transgenic animals
Jonathan R.S. Arch · 2002 · Journal of Endocrinological Investigation
Controversy in Diagnosis and Management of the Metabolic Syndrome
Stephen Brietzke · 2007 · Medical Clinics of North America
Effects of Telmisartan Therapy on Metabolic Profiles and Serum High Molecular Weight (HMW)-Adiponectin Level in Japanese Male Hypertensive Subjects with Abdominal Obesity
Naoko Komiya, Hiroshi Hirose, Hiroshi Kawabe, Hiroshi Itoh, Ikuo Saito · 2009 · Journal of Atherosclerosis and Thrombosis
l-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose
Arunkumar Elumalai, Sushil Kumar Jain · 2016 · Molecular and Cellular Biochemistry
The Insulin Sensitizer Pioglitazone Improves the Deterioration of Ischemic Preconditioning in Type 2 Diabetes Mellitus Rats
Hideki Sasaki, Kazuhiko Ogawa, Mitsuyuki Shimizu, Chikara Mori, Hisashi Takatsuka, Fumiko Okazaki, Makoto Kawai, Ikuo Taniguchi, Seibu Mochizuki · 2007 · International Heart Journal
Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
Atsunori Kashiwagi, Takashi Kadowaki, Naoko Tajima, Kenji Nonaka, Tadaaki Taniguchi, Mikio Nishii, Juan Camilo Arjona Ferreira, John M. Amatruda · 2011 · Journal of Diabetes Investigation
Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes
Akihiro Kudoh, Hiroaki Satoh, Hiroyuki Hirai, Tsuyoshi Watanabe · 2011 · Life Sciences
Plasma Adiponectin and Hyperglycaemia in Diabetic Patients
Edoardo Mannucci, Agostino Ognibene, Francesco Cremasco, Ilaria Dicembrini, Gianluca Bardini, Marco Brogi, Alessandro Terreni, Anna Lucia Caldini, Gianni Messeri, Carlo Maria Rotella · 2003 · Clinical Chemistry and Laboratory Medicine (CCLM)
Atorvastatin Administration after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease and Normal Lipid Profiles: Impact on Plasma Adiponectin Level
Kuei‐Chuan Chan, Hsi‐Hsien Chou, Chien‐Ning Huang, Ming‐Chih Chou · 2008 · Clinical Cardiology
Thiazolidinediones—improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes
Paresh Dandona, Husam Ghanim, Ajay Chaudhuri, Priya Mohanty · 2008 · Journal of Diabetes and its Complications
Effect of pituitary surgery in patients with acromegaly on adiponectin serum concentrations and alanine aminotransferase activity
Peter Wiesli, René L. Bernays, Michael Brändle, Cornelia Zwimpfer, Heidi Seiler, Jürgen Zapf, Giatgen A. Spinas, Christoph Schmid · 2004 · Clinica Chimica Acta
Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes
Akira Shimada, Toshikatsu Shigihara, Yoshiaki Okubo, Takeshi Katsuki, Yoshifumi Yamada, Yoichi Oikawa · 2011 · Diabetes/Metabolism Research and Reviews
Performance of ELISA for specific measurement of High-Molecular-Weight (HMW) adiponectin
Toshimi Tanita, Hideo Miyakoshi, Yasuko Nakano · 2008 · Journal of Immunological Methods
Effect of gliclazide modified release on adiponectin, interleukin‐6, and tumor necrosis factor‐α plasma levels in individuals with type 2 diabetes mellitus
Józef Drzewoski, Monika Żurawska-Kliś · 2006 · Current Medical Research and Opinion
CASE REPORT: Combined Treatment with Ursodeoxycholic Acid and Pioglitazone in a Patient with Nash Associated with Type 2 Diabetes and Psoriasis
Susumu Itoh, Azuma Kanazuka, Takahide Akimoto · 2003 · Digestive Diseases and Sciences
Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients
Keiji Yoshioka, Toshihide Yoshida, Tsunekazu Umekawa, Akinori Kogure, Yasuto Takakura, Hitoshi Toda, Toshikazu Yoshikawa · 2004 · Metabolism
Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia
Jeanne Margot Kroese, Christiaan F. Mooij, Marinette van der Graaf, Ad R. Hermus, Cees J. Tack · 2009 · European Journal of Endocrinology
Effects of Pioglitazone Hydrochloride on Japanese Patients with Type 2 Diabetes Mellitus
Tamio Teramoto, Nobuhiro Yamada, Kohji Shirai, Yasushi Saitō · 2007 · Journal of Atherosclerosis and Thrombosis
Cardio-oncology: the Nuclear Option
Jorge A. Alvarez, Raymond R. Russell · 2017 · Current Cardiology Reports
Plasma adiponectin as a predictive factor of survival after a bypass operation for peripheral arterial disease
Hiroyoshi Komai, Rei Shibata, Masanobu Juri, Kunihiro Matsushita, Noriyuki Ouchi, Toyoaki Murohara · 2009 · Journal of Vascular Surgery
PPARγ agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats
Baichun Yang, Peiyuan Lin, Kevin M. Carrick, Judi A. McNulty, Lisa G. Clifton, Deborah A. Winegar, Jay C. Strum, Stephen A. Stimpson, Greg L. Pahel · 2005 · Biochemical and Biophysical Research Communications
Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: Cross-sectional analysis
Oh Yoen Kim, Soo Jeong Koh, Yangsoo Jang, Jey Sook Chae, Ji Young Kim, Hyae Jin Kim, Hongkeun Cho, Jong Ho Lee · 2006 · Clinica Chimica Acta
Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures
Rocio I. Pereira, Cecilia CL Wang, Patrick W. Hosokawa, L. Miriam Dickinson, Michel Chonchol, Mori Jacob Krantz, John F. Steiner, Daniel H. Bessesen, Edward P. Havranek, Carlin S. Long · 2011 · BMC Endocrine Disorders
Adiponectin is independently associated with glycosylated haemoglobin
José Manuel Fernández‐Real, P. Botas-Cervero, A Lopez-Bermano, Roser Casamitjana, T. Funahashi, Elías Delgado, S Kihara, Wifredo Ricart · 2004 · European Journal of Endocrinology
Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients
Machi Furuta, Masanori Tamai, Tadashi Hanabusa, Yasuhisa Yamamoto, Kishio Nanjo, Tokio Sanke · 2006 · Diabetes Research and Clinical Practice
Do peroxisome proliferation receptor-γ antagonists have clinical potential as combined antiobesity and antidiabetic drugs?
Sheila Anne Doggrell · 2003 · Expert Opinion on Investigational Drugs
Adiponectin’s roles in lipid and glucose metabolism modulation in fish: Mechanisms and perspectives
Renlei Ji, Xiang Xu, Giovanni Mario Turchini, Kangsen Mai, Qinghui Ai · 2021 · Reviews in Aquaculture
Insulin Resistance: Causes and Consequences
Zachary T. Bloomgarden · 2005 · International review of neurobiology
Effects of Pretreatment with Low-dose Metformin on Metabolic Parameters and Weight Gain by Pioglitazone in Japanese Patients with Type 2 Diabetes
Toshihide Kawai, Osamu Funae, Akira Shimada, Mitsuhisa Tabata, Takumi Hirata, Yoshihito Atsumi, Hiroshi Itoh · 2008 · Internal Medicine
A Genome‐wide Scan of Loci Linked to Serum Adiponectin in Two Populations of African Descent
Chindo Hicks, Xiaofeng Zhu, Amy H. Luke, Donghui Kan, Adebowale Adeyemo, Xiaodong Wu, Richard Cooper · 2007 · Obesity
Adiponectin-Dependent and -Independent Pathways in Insulin-Sensitizing and Antidiabetic Actions of Thiazolidinediones
Naoto Kubota, Toshimasa Yamauchi, Kazuyuki Tobe, Takashi Kadowaki · 2006 · Diabetes
Effects of PPARγ ligands and C/EBPβ enhancer on expression of extracellular-superoxide dismutase
Tetsuo Adachi, Minoru Inoue, Hirokazu Hara, Seiji Suzuki · 2004 · Redox Report
Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease. To Decrease Plasma Adiponectin Levels
Kuei‐Chuan Chan, Hsi‐Hsien Chou, Der-Jinn Wu, Yi-Liang Wu, Chien‐Ning Huang · 2004 · Japanese Heart Journal
Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment
Jae Hoon Moon, Hae Jin Kim, Soo Kyung Kim, Eun Seok Kang, Byung‐Wan Lee, Chul Woo Ahn, Hyun Chul Lee, Bong Soo · 2010 · Metabolism
Screening for Adiponectin Secretion Regulators
Kyosuke Hino, Hidetaka Nagata · 2012 · Vitamins and hormones
Chapter 36 – Role of the Adipocyte in Metabolism and Endocrine Function
E. Ravussin, Steven R. Smith · 2016 · Elsevier eBooks
Changes in adiponectin level and fat distribution in patients with type 2 diabetes
Tomasz Miazgowski, Joanna Dziwura, Krzysztof Safranow, Katarzyna Iskierska, Krystyna Widecka · 2013 · European Journal of Clinical Investigation
Plasma adiponectin levels and incident glucose intolerance in Japanese–Brazilians: A seven-year follow-up study
Marcio Faleiros Vendramini, Sandra Roberta G. Ferreira, Suely G.A. Gimeno, Teresa S. Kasamatsu, Walkíria L. Miranda, Regina S. Moisés · 2006 · Diabetes Research and Clinical Practice
White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs
Yixuan Zhao, Rensong Yue · 2025 · Diabetology & Metabolic Syndrome
Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone
R. Mukhtar, J. Reckless · 2005 · Diabetic Medicine
Analytical evaluation of a high-molecular-weight (HMW) adiponectin chemiluminescent enzyme immunoassay
Suguru Hayama, Tomoko Higuchi, Hideo Miyakoshi, Yasuko Nakano · 2010 · Clinica Chimica Acta
Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats
Sheryar Afzal, Munavvar Zubaid Abdul Sattar, Edward James Johns, Olorunfemi Abraham Eseyin · 2020 · PLoS ONE
Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese
Chikako Fujii, Toshihide Kawai, Koichiro Azuma, Yuko Oguma, Fuminori Katsukawa, Hiroshi Hirose, Kumiko Tanaka, Shu Meguro, Hideo Matsumoto, Hiroshi Itoh · 2017 · Journal of Diabetes Research
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea
Pegah Khaloo, S. Asadi Komeleh, Hamid Alemi, Mohammad Alì Mansournia, A. Mohammadi, Amirhossein Yadegar, Mohsen Afarideh, Sadaf Esteghamati, Manoochehr Nakhjavani, Alireza Esteghamati · 2018 · Journal of Endocrinological Investigation
Pioglitazone increases adiponectin levels in nondiabetic patients with coronary artery disease
Snehal R. Patel, Lynn M. Mailloux, John T. Coppola, Catalin Mindrescu, Cezar S. Staniloae · 2008 · Coronary Artery Disease
High-Throughput Screening for Small-Molecule Adiponectin Secretion Modulators
Kyosuke Hino, Hidetaka Nagata, Manabu Shimonishi, Motoharu Ido · 2011 · SLAS DISCOVERY
Combination of C-reactive Protein and High Molecular Weight (HMW)-Adiponectin Reflects Further Metabolic Abnormalities Compared with Each of Them Alone in Japanese Type 2 Diabetic Subjects
Yoshifumi Saisho, Hiroshi Hirose, Yukihiro YAMAMOTO, Hiroshi Nakatani, Hiroshi Itoh · 2008 · Endocrine Journal
Adiponectin/Acrp30, an adipocyte-specific secretory factor: physiological relevance during development
Puneeth Iyengar, Philipp E. Scherer · 2003 · Pediatric Diabetes
Adipose Gene Expression Profiles Related to Metabolic Syndrome Using Microarray Analyses in Two Different Models
Hye Jin Yoo, Hwan‐Jin Hwang, Tae Woo Jung, Ja Young Ryu, Ho Cheol Hong, Hae Yoon Choi, Sei Hyun Baik, Kyung Mook Choi · 2014 · Diabetes & Metabolism Journal
Place des thiazolidinediones dans le traitement du diabète de type 2
Jean‐Frédéric Blickle · 2004 · La Presse Médicale
Dyslipidemia in Type 2 Diabetes and the Effects of Thiazolidinediones
D. Bell · 2003 · The Endocrinologist
Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Takahiro Araki, Masanori Emoto, Hisayo Yokoyama, Koka Motoyama, Tomoaki Morioka, Hideki Tahara, Hidenori Koyama, Tetsuo Shoji, Yasuhisa Okuno, Masaaki Inaba et al. · 2005 · PubMed
Zukünftige Angriffspunkte für die Therapie des Typ-2-Diabetes
Harald Stingl, Michael Roden · 2004 · Wiener klinische Wochenschrift
Effects of Losartan/Hydrochlorothiazide Treatment, After Change from ARB at Usual Dosage, on Blood Pressure and Various Metabolic Parameters Including High-Molecular Weight Adiponectin in Japanese Male Hypertensive Subjects
Hiroshi Hirose, Hiroshi Kawabe, Ikuo Saito · 2010 · Clinical and Experimental Hypertension
Evaluation of the serum visfatin and adiponectin levels in patients with type 2 diabetes mellitus
Mehmet Kara, Sema Uslu, Nur Kebapçı, Eda Yazıcı Özçelik, Cengiz Bal · 2014 · Turkish Journal of Biochemistry
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Sylvain Bellanger, Marie‐Claude Battista, Jean‐Patrice Baillargeon · 2013 · Springer eBooks
Impairment of Arterial Compliance in Cushing’s Syndrome
Pier Paolo Bassareo, Angela Maria Zedda, Giuseppe Guglielmo Mercuro · 2014 · touchREVIEWS in Endocrinology
Drug Class Review: Thiazolidinediones
Susan L. Norris, Susan Carson, Sujata Thakurta, Benjamin K S Chan · 2008
Pioglitazone — an oral antidiabetic agent and metabolic syndrome modulator. Can theory translate into practice?:
I. Campbell · 2005 · The British Journal of Diabetes
Targeting the Incretin System in Type 2 Diabetes Mellitus
Matthew V. Potenza, Elliot J. Rayfield · 2009 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
Adiponectin as a key player in inflammation
Kenneth K.Y. Cheng, Karen S.L. Lam, Yu Wang, Aimin Xu · 2006 · Biomedical Reviews
A Personalized Approach to Metabolic Aspects of Obesity
Stephen Brietzke · 2010 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocyte
Naoki Hattori, Ayato Yamada, Shunya Nakatsuji, Takeshi Matsuda, Norito Nishiyama, Akira Shimatsu · 2022 · Journal of Molecular Endocrinology
Acute psychotic stress is associated with decreased adiponectin serum levels
Eli Shiloah, Hannah Kanety, Ohad Cohen, Shula Witz, Andreas E. Buchs, Clara Pariente, Micha J. Rapoport · 2007 · Journal of Endocrinological Investigation
Metabolic Syndrome and Adipokines
Toshimasa Yamauchi, Takashi Kadowaki · 2005 · Elsevier eBooks
Letters to the Editor
Barry J. Goldstein · 2002 · Clinical Therapeutics
Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes in Relation to the Metabolic Syndrome
Andrew Drexler, Richard W. Nesto, Martin J. Abrahamson, George L. Bakris, David S.H. Bell, John D. Brunzell, Paresh Dandona, Jaime A. Davidson, Vivian Andrew Fonseca, Michael B. Fowler et al. · 2005 · Metabolic Syndrome and Related Disorders
PPARγ Agonists and Vascular Risk Factors: Potential Effects on Cardiovascular Disease
Sunil Asnani, Pierre Theuma, Vivian Andrew Fonseca · 2003 · Metabolic Syndrome and Related Disorders
Current Management of Type 2 Diabetes:Why Thiazolidinediones Should Be the Cornerstone of Therapy
Firhaad Ismail · 2004
Thiazolidinediones as PPAR Agonists
Sunder Raj D. Mudaliar, Robert R. Henry · 2004
Thiazolidinediones Could Improve Endothelial Dysfunction and Risk of Premature Coronary Heart Disease in HIV-Infected Patients
Rodolfo Carrillo-Jimenez, Gervasio A. Lamas, Charles H. Hennekens · 2002 · Journal of Cardiovascular Pharmacology and Therapeutics
Switching from Sitagliptin to Alogliptin under Treatment with Pioglitazone Increases High Molecular Weight Adiponectin in Type 2 Diabetes: A Prospective Observational Study
Akinori Tokito, Nobuyuki Koriyama, Ayako Ijuin, Kazuma Ogiso, Yoshihiko Nishio, Michihisa Jougasaki · 2015 · Journal of Diabetes Mellitus
Effects of thiazolidinediones on the triad of type 2 diabetes mellitus, insulin resistance and cardiovascular disease
John Chan, Liza L. Ilag, Meng Hee Tan · 2007 · Diabetes Research and Clinical Practice
Effects of replacing metformin with pioglitazone on glycemic control in japanese patients with poorly controlled type 2 diabetes mellitus: A 12-week, open-label, prospective study
Shinji Sakaue, Mitsunori Kamigaki, Haruhiko Yoshimura, Masaharu Nishimura · 2008 · Current Therapeutic Research
Clinical significance of serum adiponectin in Japanese diabetic patients
Yoshiya Hosokawa, Yuya Yamada, Yoshinari Obata, Megu Yamaguchi Baden, Kenji Saisho, Arisa Ihara, Koji Yamamoto, Kiyonori Katsuragi, Yūji Matsuzawa · 2011 · Diabetology International